What sector does Astrana Health, Inc. belong to?

Astrana Health, Inc. operates in the Health Care sector, specifically the Health Care Facilities industry, and is listed on the US markets.

What is the current share price of ASTH?

As of the latest available quote, ASTH traded at $37.98. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of ASTH?

Astrana Health, Inc. has a price-to-earnings (P/E) ratio of about 46.32. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of ASTH?

The market capitalisation of Astrana Health, Inc. is approximately $1.86B.

Is Astrana Health, Inc. profitable?

For its latest reported financial year, Astrana Health, Inc. recorded a net profit margin of about 0.71%.

Does ASTH pay a dividend?

Astrana Health, Inc. does not currently show a dividend yield in our data.

What is the return on equity (ROE) of ASTH?

Astrana Health, Inc. has a return on equity (ROE) of about 2.71%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of ASTH?

Over the past 52 weeks, ASTH has traded between a low of $18.08 and a high of $51.60.

Astrana Health, Inc.

ASTH US Health Care Health Care Facilities

S&P 600

$37.98

-0.13%

Delayed · cached 15 min

Fair value analysis

ASTH

Astrana Health, Inc.

$37.98

Close used for this calculation

$16.92Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

23/100

Profitability9/25

Returns1/25

Balance Sheet11/25

Efficiency2/25

Growth1/25

Weak

Quality radar

Consensus fair value

$16.92

Above FV

▼ -55.5% against the close used

Model range $0.59 – $27.21

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$0.59Fair value$16.92Bull$27.21

FairClose

52-week traded range

52W low $18.1652W high $49.81

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Astrana Health, Inc. closed at $37.98, 124.5% above the consensus fair value of $16.92 drawn from 8 valuation models.

Financial DNA score 23/100 — Weak. P/E of 82.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$27.21

-28.3%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=1.3%, r=10%, tg=3%, n=10yr

Graham Number

$13.13

-65.4%

√(22.5 × EPS × BVPS)

EPS=0.46, BVPS=16.66 · outside Graham range (P/E 82.6, P/B 2.3) — asset-light, treat as a rough floor

P/E Fair Value

$9.20

-75.8%

EPS × 20x (sector P/E)

EPS=0.46, Sector P/E=20x

Peter Lynch (PEG)

$0.59

-98.4%

EPS × Growth% (PEG = 1 is fair)

EPS=0.46, g=1.3%

EV/EBITDA

$14.60

-61.6%

(EBITDA × 10.6x − Net Debt) ÷ Shares

EBITDA=124.27M

Book Value (P/B)

$4.51

-88.1%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=16.66, ROE=2.7%, g=3%, r=10%

Reverse DCF

$37.98

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 26.4% | Historical: 1.3%

Margin of Safety

$12.39

-67.4%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=16.51, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer